Notice of Settlement Approval in Canadian OxyContin® and OxyNEO® Litigation
A Canada-wide settlement has been reached in several proposed class actions relating to the prescription drugs OxyContin® and OxyNEO®.
- A Canada-wide settlement has been reached in several proposed class actions relating to the prescription drugs OxyContin® and OxyNEO®.
- The Courts each issued orders (the "Approval Orders") approving the national Settlement Agreement (the "Settlement") as being fair, reasonable and in the best interest of Class Members.
- The approved Settlement therefore settles all litigation in Canada relating to OxyContin® and OxyNEO®.
- If, for any reason, this deadline is extended, any such extension and new Deadline will be posted at the settlement website: www.oxycontinclassactionsettlement.ca .